In G1 metastatic GEP-NET with small lesions visible on PET dotatate, very low burden of disease on CT and no clinical symptoms, are there any data to suggest early lanreotide changes natural history of disease and prolongs OS vs observation until symptoms?  

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at Albert Einstein College of Medicine of Yeshiva University
Thank you. Would you consider a resected SBO "symp...
Medical Oncologist at Mayo Clinic
I would be careful with a h/o SBO, especially of p...
Sign in or Register to read more